Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Tenaya Therapeutics ( (TNYA) ).
On January 24, 2025, Tenaya Therapeutics’ Compensation Committee approved a repricing of underwater stock options for employees and certain service providers, reducing the exercise price to $1.21 per share. This initiative aims to retain and motivate staff without causing stock dilution or increasing cash compensation, addressing the challenge of substantial underwater options as the company seeks to align employee incentives with shareholder interests.
More about Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company focused on developing therapeutics for heart disease, utilizing both gene therapy and regenerative medicine approaches to address unmet medical needs in cardiovascular health.
YTD Price Performance: -19.72%
Average Trading Volume: 5,248,338
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $95.86M
For detailed information about TNYA stock, go to TipRanks’ Stock Analysis page.
